Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Antihypertensive Class Labeling Public Health Impact Assessment Being Considered By FDA

Apr 25 2006

• By Andrew Kasper

Related Content

FDA Antihypertensive Draft Class Labeling To Be Reviewed By Cardio-Renal Committee

Dec 22 2006

Antihypertensive Indications Should Include Benefit On Cardiac Outcomes, Cmte. Says

Jun 15 2005

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window